Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. Our high purity 99% white powder formulation shows superior efficacy in glucose control and weight loss studies compared to selective GLP-1 agonists.
As a leading supplier, we offer competitive tirzepatide costco pricing for research institutions and pharmaceutical developers. The compound demonstrates greater affinity for GIP receptors while maintaining GLP-1 receptor activity, producing enhanced hyperglycemia reduction in preclinical models.
Our facility provides custom formulations from 2mg to 50mg vials with optional private labeling. All batches undergo rigorous third-party testing to ensure pharmaceutical grade purity and consistency. The tirzepatide costco program offers significant savings for bulk research quantities.
For research use only. Not for human consumption. Tirzepatide has shown promise in diabetes research through its unique dual agonist mechanism, potentially offering advantages over single-pathway treatments in current clinical development.